Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Graz
About this trial
The investigators will evaluate the implementation of a treatment bundle (Fibrinogen, Plasma and Tranexamic Acid)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aged, or believed to be aged
18 years or above
confirmed or suspected life-threatening bleeding from trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss)
need for volume replacement therapy.
Disqualifiers
patient with known recent history of thromboembolic events within the last 6 months
known or suspected pregnancy at presentation
patient with known refusal of a participation in this clinical trial.
Trial population
Patients in haemorrhagic shock that are being treated by one of the prehospital emergency systems of the Medical University of Graz (HEMS, emergency car)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of patients with successful prehospital bundle transfusion
to assess feasibility
Time frame
prehospital settingSecondary outcomes
1
30-day-mortality
Time frame
30 days2
blood product used in the first 24 hours
Time frame
24 hours3
concentration of lactat acid ad admission
measured in the emergency department
Time frame
2 hoursSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov